The occurrence of variants of the erythrocyte B agglutinogen, although rare, is of considerable practical importance because it may lead to errors in blood grouping. Subgroups of the B antigen have not been established although variants have been described. Moullec and co-workers 6 reported a weakly reacting B antigen in 1955. They named it B 3 . In 1958 Levine and associates 4 described the genetically determined phenotype B w , which also reacted as a weak B antigen. One year later Cameron and associates 2 and Giles and co-authors 3 reported the occurrence of a weak B antigen together with anti-B antibody in additional persons. They assumed that the antigen was acquired during old age and chronic disease. In 1961 Morrow and associates 5 described a weak erythrocyte B agglutinogen that coexisted with anti-B antibody. They associated it with the blood group A b that had been described by Andersen 1 1 year previously.
MATERIALS AND METHODS
Agglutination, typing, and elution studies were performed according to accepted bloodbanking procedures. Crude trypsin (Difco, 1:250), obtained from Difco Company, Detroit 1, Michigan, was used in a buffered saline solution of pH 7.3 . Bromelase (Dade Reagents, Inc., Miami, Florida) was the source of bromelin used in these studies.
A modification of the method of Kunkel and Slater for starch block electrophoresis 8 was used for the primary separation of the patient's serum. Further isolation of the antibody was effected by column chromaReceived, July 27, 1962; accepted for publication December 5.
Miss Clafiin is supervising technologist of the Blood Transfusion Service. Dr. Zinneman is the chief of the Infectious Disease Section, Medical Service, and Associate Professor, Department of Medicine, University of Minnesota School of Medicine. tography on diethylaminoethyl cellulose, as outlined in the following steps. Diethylaminoethyl cellulose (Eastman Organic Chemicals), i.e., DEAE, was prepared for use by means of suspending it in 0.5 M NaOH. Thereafter, it was washed with water until neutral and equilibrated with the starting buffer for chromatography. The water used for preparation of the ion exchanger and reagents was distilled, deionized, and passed through a cellulose column. The electrophoretically separated fractions containing the anti-B antibodies were pooled and dialyzed against 150 volumes of the starting buffer and were then applied to the chromatography column in a volume of 5 ml. Elution was begun with 0.0175 M phosphate buffer of pH 6.3, followed by a gradient to 0.04 M phosphate buffer of pH 5.9, which was followed in turn by a 0.1 M phosphate buffer of pH 5.8 , and was completed by frontal elution with 0.4 M NaH 2 P0 4 . Ten-milliliter fractions were obtained with an automatic fraction collector. Elution was followed by measurement of the ultraviolet absorbancy at 280 m/z. Immunoelectrophoresis of the purified fractions was performed according to the principles of Scheidegger's micromethod, 7 but with templates and a borate-phosphate buffer of pH 8. 2 .
R E P O R T OF CASE
A 66-year-old white man was admitted to the Minneapolis Veterans Administration Hospital on December 4,1961, with diarrhea, vomiting, and pain in the right lower quadrant. A previous hospitalization had revealed a duodenal ulcer and evidence of hepatic cirrhosis. The patient had not received blood transfusions at any time.
The physical examination revealed tenderness in the epigastrium and the right lower quadrant of the abdomen. Laboratory procedures demonstrated normal red and TABLE 
T H E GENOTYPES OF THE P A T I E N T AND H I S IMMEDIATE

T A B L E 3 T A B L E 4 AGGLUTINATION T I T E R S OBTAINED WITH A SERUM THAT CONTAINED H I G H T I T E R S OF A N T I -B FOR SALINE SOLUTION, AS WELL AS IMMUNE A N T I B O D I E S
AGGLUTINATION T I T E R S OBTAINED WITH R E D C E L L S OF NORMAL P E R S O N S OF T Y P E B AND T H O S E OF THE P A T I E N T *
SPECIAL STUDIES
The genotypes of the red cells of the patient, his wife, and his daughter are listed in Table 1 , and indicate that there was no B agglutinogen in the red cells of any of them. Specimens from the patient's siblings could not be obtained. Further observations revealed that the B antigen of the patient's
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erythrocytes was rather weak (Table 2) . This finding was also confirmed by a comparison of his erythrocytes with those of normal persons of type B (Table 3) , and with a serum of high anti-B titers for saline solution, as well as immune antibodies (Table 4) . This antigen could not be removed by means of washings with warm isotonic salt solution or by heating to 56 C.
Seventeen positive agglutination reactions were obtained when the patient's erythrocytes were incubated with the serums of 46 normal persons of blood type A. The serums of 10 normal persons of type 0 were absorbed with A antigen, and 7 positive reactions were obtained thereafter when these absorbed serums were incubated with the patient's erythrocytes.
Trypsin enhanced the reaction and resulted in a consistent increase of titers. The addition of bromelin completely abolished agglutination. Inasmuch as the weak B antigen appeared to be destroyed or removed from the erythrocytes by bromelin, its recovery was attempted from a bromelin eluate after incubation for 1 hr. at room temperature. This attempt was unsuccessful, either because the antigen was not present in the eluate, or because it was present in amounts too small to provide convincing demonstration, or because it had undergone denaturation. Further studies in this direction were not possible, as a result of the patient's death.
The antibody in the patient's serum was available for further characterization. With starch block electrophoresis, it seemed to migrate with the fast y and /3 globulins. These fractions were then passed through a DEAE cellulose ion-exchange chromatography column, with 4 successive phosphate buffers of diminishing pH and increasing molarity, as described above. The anti-B antibody was observed in the terminal peak that emerged with the 0.4 M phosphate buffer at pH 5.3 (Fig. 1) . On Immunoelectrophoresis, this protein appeared as a single line characteristic of a /32M globulin (Fig. 2) . These characteristics are compatible with a normal isohemagglutinin.
COMMENTS
The B antigen (agglutinogen) in this and previously described patients seems to differ from the normal erythrocyte agglutinogen. As an antigen, it is weaker than those of the red cell of normal persons of type B. The presence of anti-B, and the fact that it was present in normal titers, is evidence against the possibility that we were dealing with a "normal" B antigen. The possibility of a genetic determination is not very likely in this patient, yet it can not be entirely ruled out, inasmuch as studies were not made beyond the members of his immediate family. It is interesting that this patient had an adenocarcinoma of the colon. In 3 similar cases 2 ' 3> 6 the patients also suffered from cancer, some originating in the colon, whereas others occurred in the uterus.
We may then speculate that the new antigen, which attached itself to the patient's erythrocytes, had some antigenic determinants in common with the B agglutinogen. It would have been interesting, indeed, to attempt a recovery of this antigen from the tumor per se. Such an effort should be made at similar opportunities in the future.
The combination of starch block electrophoresis and ion-exchange chromatography with DEAE columns impresses the authors as a valuable procedure for the separation and purification of some specific antibodies from other y and /3 globulins. SUMMARY A patient with adenocarcinoma of the colon had anti-B antibodies in his serum. In addition to the major A agglutinogen, his red cells had a weak antigen that resulted in agglutination with anti-B typing serums but not with his own serum.
It is assumed that (1) the antigen was acquired, and that (2) it had some antigenic determinants in common with the normal B agglutinogen. The anti-B antibody was isolated, and its features were consistent with the criteria for a normal isohemagglutinin. SUMMARIO 
IN INTERLINGUA
Un patiente con adenocarcinoma del colon habeva anticorpore anti-B in su sero.
A parte le major agglutinogeno A, su erythrocytes habeva un debile antigeno que resultava in agglutination con seros de typo anti-B sed non con su proprie sero.
Se assume que (1) le antigeno esseva acquirite e que (2) illo habeva determinantes antigenic in commun con le normal agglutinogeno B. Le anticorpore anti-B esseva isolate, e su characteristicas satisfaceva le criterios pro un isohemagglutinina normal.
